Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -8.52% is 51% above its 5-year average of -17.38%, around the middle of its 5-year range (-579.95%–287.74%).
117.35% below its 12-month average of 49.11%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -12.23%.
OPERATING MARGIN
-8.52%
OPERATING MARGIN AVG TTM
49.11%
OPERATING MARGIN AVG 3Y
-129.13%
OPERATING MARGIN AVG 5Y
-17.38%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-117.35%
CURRENT VS 3Y AVG
+93.40%
CURRENT VS 5Y AVG
+50.98%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 644 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Definitive Healthcare Corp.
Market Cap
$105.01M
Operating Margin
-8.52%
TTM Avg
49.11%
3Y Avg
-129.13%
5Y Avg
-17.38%
Market Cap
$106.08M
Operating Margin
-6.27%
TTM Avg
-11.63%
3Y Avg
-15.25%
5Y Avg
-16.56%
Market Cap
$102.66M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$108.01M
Operating Margin
28.39%
TTM Avg
14.20%
3Y Avg
7.10%
5Y Avg
4.73%
Market Cap
$108.39M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1578.22%
Market Cap
$108.98M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$109.07M
Operating Margin
-6.06%
TTM Avg
-25.69%
3Y Avg
-34.32%
5Y Avg
-39.92%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Definitive Healthcare Corp. (DH) | $105.01M | -8.52% | 49.11% | -129.13% | -17.38% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.08M | -6.27% | -11.63% | -15.25% | -16.56% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $102.66M | 0.00% | 0.00% | 0.00% | 0.00% |
| The Joint Corp. (JYNT)vs › | $102.57M | 2.45% | -2.63% | -0.94% | 2.21% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.01M | 28.39% | 14.20% | 7.10% | 4.73% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.39M | 0.00% | 0.00% | 0.00% | -1578.22% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $108.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| Apyx Medical Corporation (APYX)vs › | $109.07M | -6.06% | -25.69% | -34.32% | -39.92% |
| Immunic, Inc. (IMUX)vs › | $109.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Anixa Biosciences, Inc. (ANIX)vs › | $100.54M | 0.00% | 0.00% | -1310.83% | -1301.48% |
Gross Margin
71.7%
Operating Margin
-8.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -12.23% |
| 2026-03-31 | -8.65% |
| 2025-12-31 | 287.74% |
| 2025-09-30 | -14.47% |
| 2025-06-30 | -6.86% |
| 2025-03-31 | -312.19% |
| 2024-12-31 | -159.84% |
| 2024-09-30 | -359.45% |
| 2024-06-30 | -579.95% |
| 2024-03-31 | -25.60% |
| 2023-12-31 | -15.29% |
| 2023-09-30 | -452.17% |
| 2023-06-30 | -19.80% |
| 2023-03-31 | -20.73% |
| 2022-12-31 | -17.39% |
| 2022-09-30 | -17.54% |
| 2022-06-30 | -21.78% |
| 2022-03-31 | -23.07% |
| 2021-12-31 | -31.33% |
| 2021-09-30 | -9.34% |
| 2021-09-17 | -16.63% |
| 2021-03-31 | -5.84% |
| 2020-12-31 | -20.65% |
| 2020-09-30 | -3.13% |
| 2020-06-30 | -10.71% |
| 2020-03-31 | -12.00% |
